PLUS1
1,344.80
1.00 (0.07%)
1.00 (0.07%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
|
|
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
|
|
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
$88.69
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Glaxosmithkline Plc | GSK | London | Ordinary Share | GB0009252882 | ORD 25P |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 1.00 | 0.07% | 1,344.80 | 12:35:03 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 1,344.80 | 1,334.80 | 1,358.20 | 1,339.80 | 1,343.80 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1,346.60 | 1,347.20 | 0.60 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 14,711 | 6,242,550 | 1,348.20p | 84,162,246p | - | 1,324.40 - 1,857.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:55:32 | O | 6,872 | 1,345.183p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Glaxosmithkline Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 67.42Bp | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Glaxosmithkline News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/24/2020 | 00:30 | Dow Jones News | To Find a Coronavirus Vaccine, GlaxoSmithKline Is Bonding.. |
| 10/22/2020 | 07:34 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Holding(s) in Company |
| 10/20/2020 | 08:28 | Alliance News |  IN THE KNOW: GSK Set To Report Weak 3rd Quarter But Future.. |
| 10/16/2020 | 07:41 | Alliance News | Glaxo's ViiV Gets Vocabria Boost From European Regulator |
| 10/16/2020 | 07:18 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Positive CHMP opinion ViiV long-acting.. |
| 10/14/2020 | 10:30 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 10/14/2020 | 10:29 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
Glaxosmithkline Discussion Forums - GSK
| Date | Time | Comments | Title |
|---|---|---|---|
| 10/15/2020 | 10:09 | - | Decitabine has been shown to induce cancer-testis antigen |
| 10/14/2020 | 15:18 | - | SITC Decitabine gene modulation sensitizes human non–small cell lung |
| 9/12/2020 | 09:12 | - | Going forward, I would like them to transduce |
| 9/12/2020 | 09:04 | - | Lyell plan to use defined cell populations [1], |
| 9/08/2020 | 12:41 | - | Hopefully, trials testing these improvements will start early |
| 9/08/2020 | 11:29 | - | A new trial testing the NY-ESO-1 TCR-T cell |
| 8/09/2020 | 06:16 | - | Better Development Tools for a New Golden Era |
| 8/05/2020 | 18:57 | - | Calls might sky rocket tomorrow |
| 7/31/2020 | 13:08 | - | Calls for next month |
| 5/18/2020 | 11:26 | - | Trump promises Cincinnati rally that US will end |
Historical GSK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1,411.40 | 1,421.20 | 1,324.40 | 1,355.27 | 7,127,501 | -66.60 | -4.72% |
| 1 Month | 1,485.00 | 1,489.20 | 1,324.40 | 1,412.73 | 7,697,353 | -140.20 | -9.44% |
| 3 Months | 1,533.20 | 1,619.20 | 1,324.40 | 1,478.73 | 6,992,494 | -188.40 | -12.29% |
| 6 Months | 1,689.60 | 1,742.40 | 1,324.40 | 1,574.98 | 7,797,421 | -344.80 | -20.41% |
| 1 Year | 1,702.80 | 1,857.00 | 1,324.40 | 1,615.83 | 9,308,919 | -358.00 | -21.02% |
| 3 Years | 1,411.00 | 1,857.00 | 1,236.40 | 1,539.04 | 9,143,486 | -66.20 | -4.69% |
| 5 Years | 1,370.00 | 1,857.00 | 1,236.40 | 1,537.00 | 9,049,226 | -25.20 | -1.84% |
